PODD240816C250000
- 1.75
- 0.000.00%
Insulet Newsroom
$1000 Invested In This Stock 15 Years Ago Would Be Worth $26,000 Today
Insulet (NASDAQ:PODD) has outperformed the market over the past 15 years by 12.29% on an annualized basis producing an average annual return of 24.43%. Currently, Insulet has a market capitalization
All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy
CereVasc Announces Appointments of New Directors
CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today announced the following...
Should You Think About Buying Insulet Corporation (NASDAQ:PODD) Now?
Today we're going to take a look at the well-established Insulet Corporation (NASDAQ:PODD). The company's stock led the NASDAQGS gainers with a relatively large price hike in the past couple of
Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Insulet (NASDAQ:PODD) has outperformed the market over the past 15 years by 12.41% on an annualized basis producing an average annual return of 25.12%. Currently, Insulet has a market capitalization
Glaukos Cut as Citi Reviews U.S. MedTechs
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced plans to release its financial results for the
(PODD) - Analyzing Insulet's Short Interest
Insulet's (NYSE:PODD) short percent of float has fallen 9.44% since its last report. The company recently reported that it has 2.71 million shares sold short, which is 5.18% of all regular shares that
Why Insulet Corporation (NASDAQ:PODD) Looks Like A Quality Company
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). By way of learni
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Wells Fargo Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $240
Wells Fargo analyst Larry Biegelsen maintains $Insulet(PODD.US)$ with a buy rating, and maintains the target price at $240.According to TipRanks data, the analyst has a success rate of 58.9% and a tot
Form 144 | Insulet(PODD.US) Insider Proposes to Sell 4.07 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 25, $Insulet(PODD.US)$ Insider Petrovic Shacey intends to sell 20,000 shares of its common stock on Jun 25, with a total market value of approximately $4.07 million. Sou
Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2 -- Barrons.com
An automated insulin pump markedly improved the health of patients with Type 2 diabetes, the pump maker Insulet told a conference last weekend. The company is asking regulators to clear its Omnipod pump as the first automated dispenser for the 30 million Americans with the disorder.
Is weight loss medicine or stock market bomb? Eli Lilly and Co's new drug tirzepatide caused a sharp drop in sleep device stocks.
The recent clinical trial results of the new weight loss drug tirzepatide have not only caused a sensation in the medical community, but also stirred up waves in the stock market.
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
Tandem Diabetes, DexCom See Weakness Following ADA Conference
Jefferies Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $260
Jefferies analyst Matthew Taylor maintains $Insulet(PODD.US)$ with a buy rating, and maintains the target price at $260.According to TipRanks data, the analyst has a success rate of 60.9% and a total
TD Cowen Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $264
TD Cowen analyst Josh Jennings maintains $Insulet(PODD.US)$ with a buy rating, and maintains the target price at $264.According to TipRanks data, the analyst has a success rate of 50.8% and a total av
Insulet Plans Label Expansion for Omnipod in Type 2 Diabetes